![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
SHL Telemedicine Ltd | NASDAQ:SHLT | NASDAQ | Depository Receipt |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 5.28 | 2.16 | 5.50 | 5.28 | 5.28 | 5.28 | 63 | 21:00:05 |
|
Form 20-F ☒
|
| |
Form 40-F ☐
|
|
|
Exhibit
|
| |
Description
|
|
| 99.1 | | | | |
| 99.2 | | | | |
| 99.3 | | | |
Identity of Person or Group
|
| |
Amount
Owned |
| |
Share
Options Current |
| |
Percent
of Class |
| |||||||||
Mrs. Mengke Cai (Zhuhai, China) and Kun Shen (Hong Kong, China)(1)
|
| | | | 5,969,413 | | | | | | | | | | | | 36.4% | | |
More Provident Funds (Ramat Gan, Israel)
|
| | | | 1,812,525 | | | | | | | | | | | | 11.1% | | |
Value Base Group (Tel Aviv, Israel)(2)
|
| | | | 1,406,236(3) | | | | | | | | | | | | 8.6% | | |
Yariv Alroy (Herzliya, Israel)
|
| | | | 801,456 | | | | | | 250,000 | | | | | | 6.3% | | |
Danbar Finance Ltd. (Tel Aviv, Israel)(4)
|
| | | | 802,426(5) | | | | | | | | | | | | 4.9% | | |
Sphera Funds Management (Tel Aviv, Israel)
|
| | | | 632,256(6) | | | | | | | | | | | | 3.9% | | |
| SHL or the Company | | | SHL Telemedicine Ltd. | |
| Group | | | The Company and its subsidiaries and affiliates | |
| Companies Law | | | Companies Law 5759- 1999 as in effect from time to time. | |
| Board | | | The board of directors of the Company. | |
| Director | | | Member of the Board. | |
|
Compensation Committee
|
| | The compensation committee of the Company as duly appointed from time to time in accordance with applicable law. | |
| CEO | | | Chief Executive Officer of the Company. | |
| VP | | | A chief business manager, a deputy general manager, vice general manager, any person who holds such position in the Company even if such person holds a different title and any other manager/officer in the Company who reports directly to the CEO. | |
| Executive Officers | | | CEO and VPs. | |
| Officers | | | As such term is determined under the Companies Law. | |
| Base Salary | | | Fixed gross monthly salary in exchange for the work of the Executive Officer. | |
| Management Fees | | |
Fixed monthly payment in exchange for services provided by an Officer through a management or consulting contract against a proper invoice.
For the purpose of the Compensation Policy, the Base Salary of such Officer shall be:
a.
Deemed to be equal to 70% of the total monthly consideration paid for his services, under such invoice, excluding VAT. Or;
b.
For Officers whose company car tax liability is grossed up and paid by the Company, shall be deemed to be equal to 70% of the total monthly consideration paid for his services, under such invoice, excluding VAT.
|
|
| Employee Benefits | | | The compensation of each Executive Officer who is an employee of the Company may include additional benefits such as social benefits, severance payment, pension insurance, managers insurance, or study fund, subject to applicable law. The compensation of Executive Officers (whether employees or service providers) may also include fringe benefits such as medical insurance, car allowance, mobile phone allowance and reimbursement for other expenses incurred for the purpose of carrying out his or her duties, with or without grossing up of such benefits, all in accordance with applicable law and Company’s policies as in effect from time to time, and all subject to this Compensation Policy. | |
Group
|
| |
Measurable KPI
|
| |
Qualitative
Evaluation |
| |||
|
Group / Company
|
| |
Individual
|
| |||||
CEO
|
| |
80% – 100%
|
| | | | |
Up to 20%
|
|
VPs
|
| |
Up to 100%
|
| |
Up to 60%
|
| |
Up to 20%
|
|
Group
|
| |
Group Company
|
| |
Individual
|
|
VPs | | |
— Budget targets
— Capital raise
— Cash flow targets
— Profit targets
|
| |
— Number of patientssubscribers
— Meet objectives of product development
— Gain new business
— For creating new strategic & commercial collaborations.
— Sales targets, including by geographical areas andor from new products
— Individual department budget
|
|
| Company: | | | | | | ||
|
Name of Company:
|
| | SHL Telemedicine Ltd. | | |||
|
Address:
|
| | 90 Yigal Alon Street, Ashdar Building, Tel-Aviv, Israel | | |||
|
Company Registration No.:
|
| | 511149874 | | |||
|
Meeting Date and Time:
|
| | February 8, 2024 at 17:00 Israel Time | | |||
|
Type of Meeting:
|
| | Annual General Meeting | | |||
|
Record Date:
|
| | January 4, 2024 | | |||
| Shareholder: | | | | | | | |
|
Name:
|
| |
|
| | | |
|
Israeli ID Number:
|
| |
|
| | | |
| For a non-Israeli shareholder: | | | | | | | |
|
(a)
Passport Number:
|
| |
|
| | | |
|
(b)
Issued in (indicate country):
|
| |
|
| | | |
|
(c)
Valid until (add date):
|
| |
|
| | | |
| For a shareholder who is an entity: | | | | | | | |
|
(a)
Entity Registration No.:
|
| |
|
| | | |
|
(b)
State of registration:
|
| |
|
| | ||
|
Number of Shares:
|
| |
|
| |
1 Year SHL Telemedicine Chart |
1 Month SHL Telemedicine Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions